A 25-gene classifier predicts overall survival in resectable pancreatic cancer

BACKGROUND: Pancreatic carcinoma is one of the most lethal human cancers. In patients with resectable tumors, surgery followed by adjuvant chemotherapy is the only curative treatment. However, the 5-year survival is 20%. Because of a strong metastatic propensity, neoadjuvant chemotherapy is being te...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Med
Autors principals: Birnbaum, David J., Finetti, Pascal, Lopresti, Alexia, Gilabert, Marine, Poizat, Flora, Raoul, Jean-Luc, Delpero, Jean-Robert, Moutardier, Vincent, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5606023/
https://ncbi.nlm.nih.gov/pubmed/28927421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0936-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars